Prof. Dr. med. Andreas Mackensen (Chief Physician in Oncology)

Rating : 10/10 (⭐⭐⭐⭐⭐)

🔹Prof. Dr. med. Andreas Mackensen completed his medical education at Albert-Ludwigs-Universität Freiburg, where he obtained his medical degree in 1988.

🔹His academic journey has been marked by significant achievements, including his appointment as Chair Holder (W3) and Director of the Medical Clinic 5 specializing in Hematology and Internal Oncology at the University Hospital Erlangen since 2007.

🔹Previously, from 1999 to 2007, he held the position of Professor (C3) and Senior Physician in the Department of Hematology and Internal Oncology at the University Hospital Regensburg.

🔹In addition to his clinical roles, Prof. Dr. Mackensen has made notable contributions to the field of medicine. In 2018, he served as the Co-Speaker of the Transregio SFB TRR221, DFG, focusing on "Modulation of graft-versus-host and graft-versus-leukemia immune responses after allogeneic stem cell transplantation," collaborating with experts in Regensburg (Prof. W. Herr) and Würzburg (Prof. H. Einsele).

🔹Further advancing his academic career, in 2007, Prof. Dr. Mackensen was appointed as Chair Holder (W3) for Hematology and Internal Oncology at the University Hospital Erlangen. His significant research contributions include serving as the Speaker and Leader of the clinical research group KFO146, DFG, concentrating on "Cell-mediated suppression of auto- and alloreactive immune reactions" in 2006.

🔹Prof. Dr. Mackensen's commitment to medical research and education is evident through his academic achievements. He was appointed as a C3-Professor for Hematology at the University of Regensburg in 1999 and successfully completed his Habilitation in Internal Medicine at Albert-Ludwigs-Universität Freiburg in 1998.

His educational journey began with his medical examination at Albert-Ludwigs-Universität Freiburg in 1988, where he also studied Human Medicine from 1981 to 1988.